MktsMarkets

Spruce Biosciences, Inc.
NASDAQ: SPRBKey statistics
SPRB News
Stories mentioning SPRB from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 697.00 | 602.00 | 1,610 | |
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | |||||||
| Operating Expenses | ||||||||
| Research & Development | 7,575 | 4,104 | 5,011 | (430.00) | 10,837 | 21,457 | 6,554 | 8,090 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 11,987 | 11,100 | 8,229 | 2,692 | 14,492 | 24,771 | 10,010 | 11,646 |
| Operating Income (Loss) | (11,987) | (11,100) | (8,229) | (2,692) | (14,492) | (24,074) | (9,408) | (10,036) |
| Interest Income | ||||||||
| Interest Expense | 674.00 | 6.00 | 19.00 | 29.00 | 36.00 | 56.00 | 71.00 | 83.00 |
| Other Expense | 808.00 | 938.00 | ||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (12,266) | (14,646) | (8,212) | (2,067) | (14,041) | (23,559) | (8,671) | (9,181) |
| Earnings Per Share (Basic) | (8.94) | (19.10) | (14.58) | (3.50) | (23.95) | (42.83) | (15.75) | (16.73) |
| Earnings Per Share (Diluted) | (8.94) | (19.10) | (14.58) | (3.50) | (23.95) | (42.83) | (15.75) | (16.73) |
| Weighted Average Shares Outstanding (Basic) | 1,372 | 767.00 | 563.00 | 591.00 | 586.00 | 550.00 | 551.00 | 549.00 |
| Weighted Average Shares Outstanding (Diluted) | 1,372 | 767.00 | 563.00 | 591.00 | 586.00 | 550.00 | 551.00 | 549.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About SPRB
Spruce Biosciences, Inc. (NASDAQ: SPRB) is a stock listed on the Nasdaq Stock Market under the ticker symbol SPRB. It last traded at $38.00 (Nov 20, 2026, 9:30 AM ET), down 6.2% on the day. That gives Spruce Biosciences a market capitalisation of $129.8M.
Over the past 52 weeks SPRB has traded between $38.00 and $115.00.
For the quarter ended Mar 31, 2026 it reported a net loss of $12.3M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$12.3M |
| Dec 31, 2025 | $0 | -$14.6M |
| Sep 30, 2025 | $0 | -$8.2M |
| Jun 30, 2025 | $0 | -$2.1M |
From Spruce Biosciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…